Aptamers Market Research Report-Global Forecast till 2027

Aptamers Market by Type (Nucleic Acid and Peptide Aptamers), Application (Diagnostics, Therapeutics Development), Technology (Selex, X-aptamer and MARAS technique), End Users (Biotechnology and Pharmaceutical Companies)-Global Forecast till 2027

ID: MRFR/LS/5167-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


The Global Aptamers Market is expected to register a growth of significant CAGR 20.2% during the forecast period (2018–2023).


Aptamers are peptide molecules which binds to the targeted lipid, protein, or nucleic acid molecules with high specificity. These are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be modified to have higher affinity and specificity to a large number of targets.


Improvements in aptamer development technologies, increasing Research and development expenditure, and an increasing number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Abundant advantages offered by these small molecules, in comparison to established antibodies, have also led to higher demand for these molecules across a wide range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth. However, aptamers have failed to meet the necessary safety and efficacy standards in clinical studies. Thus, companies had to terminate their clinical investigation during late-stage clinical studies. This factor is likely to hamper the growth of this market. In addition, other factors, such as little awareness about these technologies in middle and low-income countries and inadequate regulatory structure, may hinder the overall growth.


Segmentation


The Global Aptamers Market has been segmented on the basis of type, application, technology and end users.


On the basis of type, the market has been classified as nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers have been segmented into DNA-Based Aptamers, RNA-Based Aptamers.


On the basis of application, the market has been classified as diagnostics, therapeutics development, research and development, other applications


On the basis of technology, the market has been classified as Selex, X-aptamer and MARAS technique.


On the basis of end users, the market has been classified as academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations and other end users


On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.


The European aptamers market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The aptamers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The aptamers market in the Middle East and Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Aptamers Market Share, by Region, 2017 (%)


Global Aptamers Market Share, by Region, 2017 (%)


Source: MRFR Analysis


In the aptamers market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies and high investment and funding to support the development of aptamers. The other factor such as the growing demand for aptamer therapeutics coupled with a rise in a number of research laboratories helps to boost the market.


The European market is expected to hold the second largest market share. Factors such as a rise in research expenses, advancement of technology, the decline in human health, and the necessity for innovative and effective therapies boost the growth of the market in this region. The increasing number of small-scale start-ups, government organizations, rising number of products under clinical investigation, and growing number of academic research laboratories investigating the potential of aptamers are anticipated to support future growth of this market.


Whereas the market share in the Asia-Pacific region is also anticipated to experience growth in the near future due to access to optimal treatment facilities and growing demand for increasing government initiatives, advanced technology, better adoption rate, and rising healthcare expenditure.


The market in the Middle East & Africa is expected to account for the smallest share of the global aptamers market due to an underdeveloped healthcare sector, the dearth of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the global aptamers market are Aptamer Sciences, Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Ophthotech Corporation, Am Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Neoventures Biotechnology Inc., Somalogic, Inc., Trilink Biotechnologies, Inc., Vivonics, Inc., Noxxon Pharma, and others.


Global Aptamers Market, by Type



  • Nucleic acid aptamers

  • DNA-Based Aptamers

  • RNA-Based Aptamers

  • Peptide aptamers


Global Aptamers Market, by Application



  • Diagnostics

  • Therapeutics development

  • Research and development

  • Other applications


Global Aptamers Market, by Technology



  • Selex

  • X-aptamer

  • MARAS technique


Global Aptamers Market, by End Users



  • Academic and government research institutes

  • Biotechnology and pharmaceutical companies

  • Contract research organizations

  • Other end users


Global Aptamers Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Manufacturers and distributors

  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

  • Research institutes

  • Contract manufacturing organizations (CMOs)

  • Government associations

  • Market research and consulting firms

  • Venture capitalists and investors



Frequently Asked Questions (FAQ) :


The aptamers market is projected to grow at a 20.2% CAGR between 2018-2023.

North America is projected to command the largest share in the aptamers market.

It is widely used in research and development, therapeutics development, and diagnostics.

Increasing R&D expenditure and constant technological advances are adding market growth.

Inadequate regulatory structure may limit market growth.

Table of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Aptamers Market, by Type

6.1 Introduction

6.2 Nucleic acid aptamers

6.2.1 DNA-Based Aptamers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2 RNA-Based Aptamers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Peptide aptamers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Aptamers Market, by Application

7.1 Introduction

7.2 Diagnostics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Therapeutics development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Research and development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Other applications

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Aptamers Market, by Technology

8.1 Introduction

8.2 Selex

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 X-aptamer

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 MARAS technique

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Aptamers Market, by End-Users

9.1 Introduction

9.2 Academic and government research institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Biotechnology and pharmaceutical companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Contract research organizations

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Aptamers Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America:

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Aptamer Sciences, Inc.

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Aptagen, LLC

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

10.2.5 SWOT Analysis

12.3 Base Pair Biotechnologies, Inc.

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Ophthotech Corporation

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Am Biotechnologies, LLC

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Aptamer Solutions Ltd.

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Aptus Biotech S.L.

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Neoventures Biotechnology Inc.

12.8.1 Overview

12.8.2 Type/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Somalogic, Inc.

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Trilink Biotechnologies, Inc.

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Vivonics, Inc.

12.11.1 Overview

12.11.2 Type Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Noxxon Pharma

12.12.1 Overview

12.12.2 Type Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Others

12.13.1 Overview

12.13.2 Type Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Aptamers Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Aptamers Market Synopsis, 2020-2027

Table 2 Global Aptamers Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Aptamers Market, by Region, 2020-2027 (USD Million)

Table 4 Global Aptamers Market, by Type, 2020-2027 (USD Million)

Table 5 Global Aptamers Market, by Application, 2020-2027 (USD Million)

Table 6 Global Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 7 Global Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 8 North America: Aptamers Market, by Type, 2020-2027 (USD

Million)

Table 9 North America: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 10 North America: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 11 North America: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 12 US: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 13 US: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 14 US: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 15 US: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 16 Canada: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 17 Canada: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 18 Canada: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 19 Canada: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 20 South America: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 21 South America: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 22 South America: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 23 South America: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 24 Europe: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 25 Europe: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 26 Europe: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 27 Europe: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 28 Western Europe: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 29 Western Europe: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 30 Western Europe: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 31 Western Europe: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 32 Eastern Europe: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 33 Eastern Europe: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 34 Eastern Europe: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 35 Eastern Europe: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 38 Asia-Pacific: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 39 Asia-Pacific: Aptamers Market, by End-users, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Aptamers Market, by Type, 2020-2027 (USD Million)

Table 41 Middle East & Africa: Aptamers Market, by Application, 2020-2027 (USD Million)

Table 42 Middle East & Africa: Aptamers Market, by Technology, 2020-2027 (USD Million)

Table 43 Middle East & Africa: Aptamers Market, by End-users, 2020-2027 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Aptamers Market

Figure 3 Segmentation Market Dynamics for Global Aptamers Market

Figure 4 Global Aptamers Market Share, by Type, 2020

Figure 5 Global Aptamers Market, by End-users, 2020–2027 (USD Million)

Figure 6 Global Aptamers Market Share, by Region, 2020

Figure 7 North America: Aptamers Market Share, by Country, 2020

Figure 8 Europe: Aptamers Market Share, by Country, 2020

Figure 9 Asia-Pacific: Aptamers Market Share, by Country, 2020

Figure 10 Middle East & Africa: Aptamers Market Share, by Country, 2020

Figure 11 Global Aptamers Market: Company Share Analysis, 2020 (%)

Figure 12 Aptamer Sciences, Inc.: Key Financials

Figure 13 Aptamer Sciences, Inc.: Segmental Revenue

Figure 14 Aptamer Sciences, Inc.: Geographical Revenue

Figure 15 Aptagen, LLC: Key Financials

Figure 16 Aptagen, LLC: Segmental Revenue

Figure 17 Aptagen, LLC: Geographical Revenue

Figure 18 Base Pair Biotechnologies, Inc.: Key Financials

Figure 19 Base Pair Biotechnologies, Inc.: Segmental Revenue

Figure 20 Base Pair Biotechnologies, Inc.: Geographical Revenue

Figure 21 Ophthotech Corporation: Key Financials

Figure 22 Ophthotech Corporation: Segmental Revenue

Figure 23 Ophthotech Corporation: Geographical Revenue

Figure 24 Am Biotechnologies, LLC: Key Financials

Figure 25 Am Biotechnologies, LLC: Segmental Revenue

Figure 26 Am Biotechnologies, LLC: Geographical Revenue

Figure 27 Aptamer Solutions Ltd: Key Financials

Figure 28 Aptamer Solutions Ltd: Segmental Revenue

Figure 29 Aptamer Solutions Ltd: Geographical Revenue

Figure 30 Aptus Biotech S.L.: Key Financials

Figure 31 Aptus Biotech S.L.: Segmental Revenue

Figure 32 Aptus Biotech S.L.: Geographical Revenue

Figure 33 Neoventures Biotechnology Inc.: Key Financials

Figure 34 Neoventures Biotechnology Inc.: Segmental Revenue

Figure 35 Neoventures Biotechnology Inc.: Geographical Revenue

Figure 36 Somalogic, Inc.: Key Financials

Figure 37 Somalogic, Inc.: Segmental Revenue

Figure 38 Somalogic, Inc.: Geographical Revenue

Figure 39 Trilink Biotechnologies, Inc.: Key Financials

Figure 40 Trilink Biotechnologies, Inc.: Segmental Revenue

Figure 41 Trilink Biotechnologies, Inc.: Geographical Revenue

Figure 42 Vivonics, Inc.: Key Financials

Figure 43 Vivonics, Inc.: Segmental Revenue

Figure 44 Vivonics, Inc.: Geographical Revenue

Figure 45 Noxxon Pharma: Key Financials

Figure 46 Noxxon Pharma: Segmental Revenue

Figure 47 Noxxon Pharma: Geographical Revenue

Figure 48 Others: Key Financials

Figure 49 Others: Segmental Revenue

Figure 50 Others: Geographical Revenue